AEON

Conviction 0HealthcareScan · Mon, Aug 10, 2026

AEON$0.2781+0.36%

ResistanceSupportVol 14

Vol MA14 830.41K

May 11May 28Jun 16Jul 6Jul 23Aug 10

AEON Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.aeonbiopharma.com ↗

Price0.2781

Change+0.36%

Gap-1.88%

Rel volume0.00×

Avg volume3.16M

Avg $ vol1.07M

SMA 200.2818

SMA 500.5228

SMA 2000.8745

Price vs 50-46.80%

Price vs 200-68.20%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3670

RSI (14)29

MACD hist0.02

MACD crossbull · 7d

Stoch %K / %D47 / 48

ADX (14)53

+DI / −DI14 / 31

RSI divergence—

MACD divergence—

ATR %+14.23%

ADR %11.15%

52w high1.40

52w low0.2430

From 52w high-80.14%

Above 52w low+14.44%

New 52w highNo

SqueezeOff

Bollinger width34.84%

%B0.46

Donchian pos37.82%

Donchian high0.3700

Donchian low0.2222

AVWAP (52w high)0.3843

vs AVWAP high-27.63%

AVWAP (52w low)0.2876

vs AVWAP low-3.31%

OBV trendUp

Chaikin MF (20)0.59

Today vs 20d0.00×

Avg vol (14d)830.41K

Avg vol (20d)3.16M

Avg $ vol (20d)1.07M

Market cap7.32M

RS 3m (vs SPY)-75.25%

RS 6m (vs SPY)-88.22%

RS line new highNo

Trend template0/8

Technical rank3.4

1 week-5.73%

1 month-42.43%

3 months-69.10%

6 months-74.72%

1 year-61.01%

YTD-74.95%

P/E-0.19

P/B-0.44

P/S—

P/FCF-0.42

EPS-3.95

Div yield—

ROE234.13%

ROA-454.48%

Debt/Eq—

Current0.99

EV/EBITDA-0.08

Gross margin—

Net margin—

Rev growth—

EPS growth-193.37%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.07M

Revenue—

Net income-11.79M

Gross profit—

Free cash flow-17.31M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out26.31M

Employees8

ListedMon, Jul 24, 2023

Free float9.82M

Float %81.1%

Short interest1.11M

Days to cover0.2d

Short volume15.1%

Squeeze score24 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank3.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7449

Support0.2282

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AEON

All disclosures →

No recent disclosed trades by Congress in AEON. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AEON · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Carter Eric G Director · Class A Common Stock · 2026-06-17	Grant	222.68K	—	2026-06-17	2026-06-22
FISCHER JOST Director · Class A Common Stock · 2026-06-17	Grant	222.68K	—	2026-06-17	2026-06-22
Forth Marc Director · Class A Common Stock · 2026-06-17	Grant	222.68K	—	2026-06-17	2026-06-22
PALMISANO ROBERT J Director · Class A Common Stock · 2026-06-17	Grant	222.68K	—	2026-06-17	2026-06-22
Thunen Shelley B Director · Class A Common Stock · 2026-06-17	Grant	222.68K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in AEON · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.